Angiotensin-converting enzyme 2 mediates hyperfiltration associated with diabetes

American Journal of Physiology - Renal Physiology

Volumn 306, Issue 7, 2014, Pages

  Tikellis, Chris ^a,b   Brown, Russel ^a   Head, Geoffrey A ^b   Cooper, Mark E ^a,b   Thomas, Merlin C ^a,b  

^a BAKER IDI HEART AND DIABETES INSTITUTE   (Australia)

^b MONASH UNIVERSITY   (Australia)

Author keywords

Angiotensin; Angiotensin converting enzyme 2; Diabetes; Diabetic nephropathy; Hyperfiltration; Micropuncture

Indexed keywords

ANGIOTENSIN CONVERTING ENZYME 2; ANGIOTENSIN[1-7]; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; MLN 4760; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; C57BL 6 MOUSE; CAPILLARY PRESSURE; CONTROLLED STUDY; DIABETIC NEPHROPATHY; ENZYME ACTIVITY; GLOMERULUS FILTRATION; HYDROSTATIC PRESSURE; KIDNEY HYPERTROPHY; KNOCKOUT MOUSE; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DIET; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; ULTRAFILTRATION;

ANGIOTENSIN; ANGIOTENSIN-CONVERTING ENZYME 2; DIABETES; DIABETIC NEPHROPATHY; HYPERFILTRATION; MICROPUNCTURE;

ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANIMALS; CAPILLARIES; CREATININE; DIABETES MELLITUS, EXPERIMENTAL; DIABETIC NEPHROPATHIES; DIETARY PROTEINS; GLOMERULAR FILTRATION RATE; HYDROSTATIC PRESSURE; HYPERTROPHY; KIDNEY; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; PEPTIDYL-DIPEPTIDASE A; RENAL CIRCULATION; RENIN-ANGIOTENSIN SYSTEM;

EID: 84900523740     PISSN: 1931857X     EISSN: 15221466     Source Type: Journal    
DOI: 10.1152/ajprenal.00264.2013     Document Type: Article

References (46)

1. Benter IF, Yousif MH, Cojocel C, Al-Maghrebi M, Diz DI. Angiotensin-(1-7) prevents diabetes-induced cardiovascular dysfunction. Am J Physiol Heart Circ Physiol 292: H666-H672, 2007
2. Brown R, Ollerstam A, Johansson B, Skott O, Gebre-Medhin S, Fredholm B, Persson AE. Abolished tubuloglomerular feedback and increased plasma renin in adenosine A1 receptor-deficient mice. Am J Physiol Regul Integr Comp Physiol 281: R1362-R1367, 2001
3. Cefalu WT, Wang ZQ, Bell-Farrow A, Kiger FD, Izlar C. Glycohemoglobin measured by automated affinity HPLC correlates with both short-term and long-term antecedent glycemia. Clin Chem 40: 1317-1321, 1994
4. Crackower MA, Sarao R, Oudit GY, Yagil C, Kozieradzki I, Scanga SE, Oliveira-dos-Santos A.J, da Costa J, Zhang L, Pei Y, Scholey J, Ferrario CM, Manoukian AS, Chappell MC, Backx PH, Yagil Y, Penninger JM. Angiotensin-converting enzyme 2 is an essential regulator of heart function. Nature 417: 822-828, 2002
5. Ferrario CM, Chappell MC. Novel angiotensin peptides. Cell Mol Life Sci 61: 2720-2727, 2004
6. Hostetter TH, Troy JL, Brenner BM. Glomerular hemodynamics in experimental diabetes mellitus. Kidney Int 19: 410-415, 1981
7. Ichihara A, Hayashi M, Koura Y, Tada Y, Sugaya T, Hirota N, Saruta T. Blunted tubuloglomerular feedback by absence of angiotensin type 1A receptor involves neuronal NOS. Hypertension 40: 934-939, 2002
8. Inman SR, Porter JP, Fleming JT. Reduced renal microvascular reactivity to angiotensin II in diabetic rats. Microcirculation 1: 137-145, 1994
9. Inman SR, Stowe NT, Nally JV Jr, Brouhard BH, Vidt DG. Dietary protein does not alter intrinsic reactivity of renal microcirculation to angiotensin II in rodents. Am J Physiol Renal Fluid Electrolyte Physiol 268: F302-F308, 1995
10. Kessler SP, Hashimoto S, Senanayake PS, Gaughan C, Sen GC, Schnermann J. Nephron function in transgenic mice with selective vascular or tubular expression of angiotensin-converting enzyme. J Am Soc Nephrol 16: 3535-3542, 2005
11. Lely AT, Hamming I, van Goor H, Navis GJ. Renal ACE2 expression in human kidney disease. J Pathol 204: 587-593, 2004
12. Li N, Zimpelmann J, Cheng K, Wilkins JA, Burns KD. The role of angiotensin converting enzyme 2 in the generation of angiotensin 1-7 by rat proximal tubules. Am J Physiol Renal Physiol 288: F353-F362, 2005
13. Li P, Chappell MC, Ferrario CM, Brosnihan KB. Angiotensin-(1-7) augments bradykinin-induced vasodilation by competing with ACE and releasing nitric oxide. Hypertension 29: 394-400, 1997
14. Mitchell KD, Navar LG. Enhanced tubuloglomerular feedback during peritubular infusions of angiotensins I and II. Am J Physiol Renal Fluid Electrolyte Physiol 255: F383-F390, 1988
15. Mizuiri S, Hemmi H, Arita M, Ohashi Y, Tanaka Y, Miyagi M, Sakai K, Ishikawa Y, Shibuya K, Hase H, Aikawa A. Expression of ACE and ACE2 in individuals with diabetic kidney disease and healthy controls. Am J Kidney Dis 51: 613-623, 2008
16. O'Neill J, Corbett A, Johns EJ. Dietary sodium intake modulates the renal excretory responses to intrarenal angiotensin (1-7) administration in the anaesthetised rat. Am J Physiol Regul Integr Comp Physiol 304: R260-R266 2013
17. Park S, Bivona BJ, Kobori H, Seth DM, Chappell MC, Lazartigues E, Harrison-Bernard LM. Major role for ACE-independent intrarenal ANG II formation in type II diabetes. Am J Physiol Renal Physiol 298: F37-F48, 2010
18. Patinha D, Fasching A, Pinho D, Albino-Teixeira A, Morato M, Palm F. Angiotensin II contributes to glomerular hyperfiltration in diabetic rats independently of adenosine type I receptors. Am J Physiol Renal Physiol 304: F614-F622, 2013
19. Pihl L, Persson P, Fasching A, Hansell P, DiBona GF, Palm F. Insulin induces the correlation between renal blood flow and glomerular filtration rate in diabetes: implications for mechanisms causing hyperfiltration. Am J Physiol Regul Integr Comp Physiol 303: R39-R47, 2012
20. Ploth DW, Rudulph J, LaGrange R, Navar LG. Tubuloglomerular feedback and single nephron function after converting enzyme inhibition in the rat. J Clin Invest 64: 1325-1335, 1979
21. Reich HN, Oudit GY, Penninger JM, Scholey JW, Herzenberg AM. Decreased glomerular and tubular expression of ACE2 in patients with type 2 diabetes and kidney disease. Kidney Int 74: 1610-1616, 2008
22. Ren Y, Garvin JL, Carretero OA. Vasodilator action of angiotensin- (1-7) on isolated rabbit afferent arterioles. Hypertension 39: 799-802, 2002
23. Sallstrom J, Carlsson PO, Fredholm BB, Larsson E, Persson AE, Palm F. Diabetes-induced hyperfiltration in adenosine A1-receptor deficient mice lacking the tubuloglomerular feedback mechanism. Acta Physiol (Oxf) 190: 253-259, 2007
24. Sallstrom J, Carlstrom M, Olerud J, Fredholm BB, Kouzmine M, Sandler S, Persson AE. High-protein-induced glomerular hyperfiltration is independent of the tubuloglomerular feedback mechanism and nitric oxide synthases. Am J Physiol Regul Integr Comp Physiol 299: R1263-R1268, 2010
25. Schambelan M, Blake S, Sraer J, Bens M, Nivez MP, Wahbe F. Increased prostaglandin production by glomeruli isolated from rats with streptozotocin-induced diabetes mellitus. J Clin Invest 75: 404-412, 1985
26. Schnermann J, Levine DZ. Paracrine factors in tubuloglomerular feedback: adenosine, ATP, and nitric oxide. Annu Rev Physiol 65: 501-529, 2003
27. Schnermann JB, Traynor T, Yang T, Huang YG, Oliverio MI, Coffman T, Briggs JP. Absence of tubuloglomerular feedback responses in AT1A receptor-deficient mice. Am J Physiol Renal Physiol 273: F315-F320, 1997
28. Selen G, Muller-Suur R, Persson AE. Activation of the tubuloglomerular feedback mechanism in dehydrated rats. Acta Physiol Scand 117: 83-89, 1983
29. Seney FD Jr, Persson EG, Wright FS. Modification of tubuloglomerular feedback signal by dietary protein. Am J Physiol Renal Fluid Electrolyte Physiol 252: F83-F90, 1987
30. Smith LJ, Rosenberg ME, Hostetter TH. Effect of angiotensin II blockade on dietary protein-induced renal growth. Am J Kidney Dis 22: 120-127, 1993
31. Soler MJ, Wysocki J, Ye M, Lloveras J, Kanwar Y, Batlle D. ACE2 inhibition worsens glomerular injury in association with increased ACE expression in streptozotocin-induced diabetic mice. Kidney Int 72: 614-623, 2007
32. Thomas MC, Burns WC, Cooper ME. Tubular changes in early diabetic nephropathy. Adv Chronic Kidney Dis 12: 177-186, 2005
33. Thomas MC, Pickering RJ, Tsorotes D, Koitka A, Sheehy K, Bernardi S, Toffoli B, Nguyen-Huu TP, Head GA, Fu Y, Chin-Dusting J, Cooper ME, Tikellis C. Genetic Ace2 deficiency accentuates vascular inflammation and atherosclerosis in the ApoE knockout mouse. Circ Res 107: 888-897, 2010
34. Thomas MC, Tikellis C, Burns WC, Thallas V, Forbes JM, Cao Z, Osicka TM, Russo LM, Jerums G, Ghabrial H, Cooper ME, Kantharidis P. Reduced tubular cation transport in diabetes: prevented by ACE inhibition. Kidney Int 63: 2152-2161, 2003
35. Thomas MC, Tikellis C, Burns WM, Bialkowski K, Cao Z, Coughlan MT, Jandeleit-Dahm K, Cooper ME, Forbes JM. Interactions between renin angiotensin system and advanced glycation in the kidney. J Am Soc Nephrol 16: 2976-2984, 2005
36. Thomson SC, Deng A, Bao D, Satriano J, Blantz RC, Vallon V. Ornithine decarboxylase, kidney size, and the tubular hypothesis of glomerular hyperfiltration in experimental diabetes. J Clin Invest 107: 217-224, 2001
37. Thomson SC, Rieg T, Miracle C, Mansoury H, Whaley J, Vallon V, Singh P. Acute and chronic effects of SGLT2 blockade on glomerular and tubular function in the early diabetic rat. Am J Physiol Regul Integr Comp Physiol 302: R75-R83, 2012
38. Tikellis C, Bialkowski K, Pete J, Sheehy K, Su Q, Johnston C, Cooper ME, Thomas MC. ACE2 deficiency modifies renoprotection afforded by ACE inhibition in experimental diabetes. Diabetes 57: 1018-1025, 2008
39. Tikellis C, Pickering R, Tsorotes D, Du XJ, Kiriazis H, Nguyen-Huu TP, Head GA, Cooper ME, Thomas MC. Interaction of diabetes and ACE2 in the pathogenesis of cardiovascular disease in experimental diabetes. Clin Sci (Lond) 123: 519-529, 2012
40. Vallon V, Schroth J, Satriano J, Blantz RC, Thomson SC, Rieg T. Adenosine A1 receptors determine glomerular hyperfiltration and the salt paradox in early streptozotocin diabetes mellitus. Nephron Physiol 111: p30-p38, 2009
41. Vallon V, Thomson SC. Anomalous role for dietary salt in diabetes mellitus? Nat Rev Endocrinol 7: 377-378, 2011
42. Vallon V, Thomson SC. Renal function in diabetic disease models: the tubular system in the pathophysiology of the diabetic kidney. Annu Rev Physiol 74: 351-375, 2012
43. Woods LL, Mizelle HL, Hall JE. Control of renal hemodynamics in hyperglycemia: possible role of tubuloglomerular feedback. Am J Physiol Renal Fluid Electrolyte Physiol 252: F65-F73, 1987
44. Wysocki J, Ye M, Soler MJ, Gurley SB, Xiao HD, Bernstein KE, Coffman TM, Chen S, Batlle D. ACE and ACE2 activity in diabetic mice. Diabetes 55: 2132-2139, 2006
45. Ye M, Wysocki J, Naaz P, Salabat MR, LaPointe MS, Batlle D. Increased ACE 2 and decreased ACE protein in renal tubules from diabetic mice: a renoprotective combination? Hypertension 43: 1120-1125, 2004
46. Ye M, Wysocki J, William J, Soler MJ, Cokic I, Batlle D. Glomerular localization and expression of angiotensin-converting enzyme 2 and angiotensin-converting enzyme: implications for albuminuria in diabetes. J Am Soc Nephrol 17: 3067-3075, 2006.